Navigating Drug Price Regulation: Evaluating th...

By João L. Carapinha

April 23, 2025

The executive order "Lowering Drug Prices by Once Again Putting Americans First" establishes a policy agenda focused on drug price regulation to reduce prescription drug costs in the U.S. This initiative revisits and expands prior efforts, such as...
Capivasertib Cost-Effectiveness in Advanced Breast Cancer
Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critic...
Toripalimab Evidence Journey in Cancer Care
NICE Breakthrough: Record Positive Recommendations for Blood Cancer Treatment...
Approval of Pembrolizumab Enfortumab Therapy: Insights on Efficacy, Costs, an...
Engineering Resilience: Mastering Pharma Patent Expiration Strategy
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
Pharmacy Benefit Managers Report Reveals Escalating Drug Costs and Calls for ...
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Access to Anti-Obesity Medication for Medicare and Medicaid
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...